bosentan anhydrous has been researched along with HIV Coinfection in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Du, HA; Kuang, HY; Li, Q; Yin, YH | 1 |
| Bega, E; Carratù, P; Damiani, MF; Dragonieri, S; Resta, O; Scoditti, A; Scoditti, C | 1 |
| Camara, B; Degano, B; Humbert, M; Jaïs, X; Le Pavec, J; Savale, L; Simonneau, G; Sitbon, O; Yaïci, A | 1 |
| Sitbon, O | 1 |
| Backman, ES; Farber, HW; Hardy, H | 1 |
| Janda, S; Quon, BS; Swiston, J | 1 |
| Couderc, LJ; Metivier, AC; Rivaud, E; Tcherakian, C; Zucman, D | 1 |
| Descamps, D; Gervais, A; Larrouy, L; Le Beller, C; Lê, MP; Long, K; Mal, H; Papy, E; Peytavin, G | 1 |
| Cooper, DA; Delfraissy, JF; Fourme, T; Gressin, V; Humbert, M; Macdonald, PS; Opravil, M; Simonneau, G; Sitbon, O; Speich, R | 1 |
| Autret-Leca, E; Beau-Salinas, F; Garot, D; Ingremeau, V; Jonville-Béra, AP; Le Guellec, C | 1 |
| Barbarini, G; Barbaro, G; Giancaspro, G; Grisorio, B; Lucchini, A; Pellicelli, AM | 1 |
| Neumann, T; ten Freyhaus, H | 1 |
4 review(s) available for bosentan anhydrous and HIV Coinfection
| Article | Year |
|---|---|
Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Topics: Antihypertensive Agents; Bosentan; Connective Tissue Diseases; Exercise; Familial Primary Pulmonary Hypertension; Heart Defects, Congenital; Hemodynamics; HIV Infections; Humans; Observational Studies as Topic; Pulmonary Arterial Hypertension | 2021 |
HIV-related pulmonary arterial hypertension: clinical presentation and management.
Topics: Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Bosentan; CD4 Lymphocyte Count; Epoprostenol; Female; HIV Infections; Humans; Hypertension, Pulmonary; Male; Pulmonary Artery; Pulmonary Circulation; Receptors, Endothelin; Severity of Illness Index; Substance Abuse, Intravenous; Sulfonamides; Survival Analysis; Treatment Outcome | 2008 |
HIV and pulmonary arterial hypertension: a systematic review.
Topics: Adolescent; Adult; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Bosentan; Cardiomegaly; CD4 Lymphocyte Count; Child; Cohort Studies; Confounding Factors, Epidemiologic; Databases, Bibliographic; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Electrocardiography; Epoprostenol; Female; Hemodynamics; HIV Infections; Humans; Hypertension, Pulmonary; Male; Prevalence; Radiography; Reverse Transcriptase Inhibitors; Sulfonamides; Survival Rate; Treatment Outcome | 2010 |
[Pulmonary hypertension in HIV patients].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antihypertensive Agents; Bosentan; Cyclic Nucleotide Phosphodiesterases, Type 5; HIV Infections; Humans; Hypertension, Pulmonary; Phosphodiesterase Inhibitors; Prevalence; Prognosis; Prostaglandins; Sulfonamides | 2006 |
9 other study(ies) available for bosentan anhydrous and HIV Coinfection
| Article | Year |
|---|---|
Atrial flutter regression in HIV-associated pulmonary arterial hypertension after treatment with bosentan.
Topics: Antihypertensive Agents; Atrial Flutter; Bosentan; Female; HIV Infections; Humans; Hypertension, Pulmonary; Middle Aged; Remission Induction; Treatment Outcome | 2016 |
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.
Topics: Adult; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Bosentan; Cohort Studies; Disease-Free Survival; Drug Administration Schedule; Exercise Tolerance; Female; HIV Infections; Humans; Hypertension, Pulmonary; Male; Middle Aged; Retrospective Studies; Sulfonamides; Treatment Outcome | 2009 |
Successful bosentan and nonnucleoside reverse transcriptase inhibitor-based therapy in a patient with acquired immunodeficiency syndrome and pulmonary arterial hypertension.
Topics: Acquired Immunodeficiency Syndrome; Arteries; Bosentan; Drug Interactions; Female; HIV Infections; Humans; Hypertension; Hypertension, Pulmonary; Middle Aged; Nevirapine; Plasma; Reverse Transcriptase Inhibitors; Sulfonamides; Viral Load | 2010 |
Curing HIV-associated pulmonary arterial hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Familial Primary Pulmonary Hypertension; Female; HIV Infections; Humans; Hypertension, Pulmonary; Middle Aged; Remission Induction; Sulfonamides | 2012 |
Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
Topics: Antiviral Agents; Bosentan; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Oligopeptides; Sulfonamides | 2013 |
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Female; HIV Infections; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prospective Studies; Pulmonary Artery; Sulfonamides; Treatment Outcome | 2004 |
Possible reduction in indinavir serum concentrations by bosentan.
Topics: Adult; Antihypertensive Agents; Area Under Curve; Bosentan; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Hypertension, Pulmonary; Indinavir; Male; Metabolic Clearance Rate; Sulfonamides | 2005 |
Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension.
Topics: Adult; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Bosentan; Drug Combinations; Exercise Test; Female; HIV Infections; Humans; Hypertension, Pulmonary; Male; Middle Aged; Sulfonamides; Treatment Outcome | 2006 |
Pulmonary hypertension and HIV.
Topics: Antihypertensive Agents; Bosentan; Epoprostenol; HIV Infections; Humans; Hypertension, Pulmonary; Sulfonamides | 2002 |